Anavasi Diagnostics
PrivateLast Round
Series A
Nov 2, 2022
Total Funding Raised
$23.85M
Company Overview
Anavasi Diagnostics is a medical technology company that develops a clinical diagnostic platform designed for the rapid diagnosis of infectious diseases at the point-of-care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anavasi Diagnostics Comparables
Compare Anavasi Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AmplifiDx | 92% | |
| Novel Microdevices | 85% | |
| Kryptos Biotechnologies, Inc. | 84% |
Anavasi Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 2, 2022 | ||||
| Grant | Nov 9, 2021 | ||||
| Convertible Debt | Oct 1, 2021 | ||||
| Angel | Jan 1, 2021 | ||||
| Grant | Aug 1, 2020 |
Anavasi Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| University of Washington | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors increased 53% MoM.
- Jun 2, 2025
Monthly visitors increased 67% MoM, reaching 2.5K.
Anavasi Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Anavasi Diagnostics's valuation, stock price, and market status.
Is Anavasi Diagnostics a public or private company?
Anavasi Diagnostics is a private company.
What is the current stock price of Anavasi Diagnostics?
Anavasi Diagnostics is a private company with no public stock price. Caplight tracks Anavasi Diagnostics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Anavasi Diagnostics worth (valuation)?
Valuation information for Anavasi Diagnostics is not publicly available.
Can I buy Anavasi Diagnostics stock?
Anavasi Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Anavasi Diagnostics's last funding round?
Anavasi Diagnostics's most recent funding round was Series A on November 2, 2022.
Who are the main investors in Anavasi Diagnostics?
Key investors in Anavasi Diagnostics include NIH RADx, University of Washington.
Will Anavasi Diagnostics IPO soon?
No public IPO plans have been announced for Anavasi Diagnostics.
How can I track Anavasi Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anavasi Diagnostics's secondary market activity and sign up for updates.